An interbacterial toxin inhibits target cell growth by synthesizing (p)ppApp
Bacteria have evolved sophisticated mechanisms to inhibit the growth of competitors 1 . One such mechanism involves type VI secretion systems, which bacteria can use to inject antibacterial toxins directly into neighbouring cells. Many of these toxins target the integrity of the cell envelope, but t...
Saved in:
Published in: | Nature (London) Vol. 575; no. 7784; pp. 674 - 678 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
London
Nature Publishing Group UK
01-11-2019
Nature Publishing Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Bacteria have evolved sophisticated mechanisms to inhibit the growth of competitors
1
. One such mechanism involves type VI secretion systems, which bacteria can use to inject antibacterial toxins directly into neighbouring cells. Many of these toxins target the integrity of the cell envelope, but the full range of growth inhibitory mechanisms remains unknown
2
. Here we identify a type VI secretion effector, Tas1, in the opportunistic pathogen
Pseudomonas aeruginosa
. The crystal structure of Tas1 shows that it is similar to enzymes that synthesize (p)ppGpp, a broadly conserved signalling molecule in bacteria that modulates cell growth rate, particularly in response to nutritional stress
3
. However, Tas1 does not synthesize (p)ppGpp; instead, it pyrophosphorylates adenosine nucleotides to produce (p)ppApp at rates of nearly 180,000 molecules per minute. Consequently, the delivery of Tas1 into competitor cells drives rapid accumulation of (p)ppApp, depletion of ATP, and widespread dysregulation of essential metabolic pathways, thereby resulting in target cell death. Our findings reveal a previously undescribed mechanism for interbacterial antagonism and demonstrate a physiological role for the metabolite (p)ppApp in bacteria.
The bacterium
Pseudomonas aeruginosa
attacks competing bacteria using the toxin Tas1, which pyrophosphorylates adenosine nucleotides to generate (p)ppApp, thereby depleting ATP and disrupting multiple cellular functions. |
---|---|
Bibliography: | USDOE USHHS Canadian Institutes of Health Research (CIHR) AC02-06CH11357; HHSN272201200026C; HHSN272201700060C; P30GM124165; S10OD021527; 34531; R01-GM082899; PJT-156129 Canadian Foundation for Innovation National Institutes of Health (NIH) These authors contributed equally to this work. Author Contributions Experiments were conceived and designed by S.A., B.W., M.T.L., and J.C.W. Cloning, bacterial competition assays, protein purification, biochemical experiments and protein crystallization were carried out by S.A and B.W. X-ray data collection and analyses was performed by P.S. and R.A.G. Bioinformatics analyses for Extended Data Fig. 1 aperformed by H.R.T. and A.G.M. Assistance with cloning, purification and crystallization of Tas1-Tis1 complex provided by M.D.W. Figure design, manuscript writing and editing done by S.A., B.W., M.T.L., and J.C.W. Project was supervised by M.T.L. and J.C.W. Funding for project provided by A.S., R.A.G., A.G.M., M.T.L. and J.C.W. |
ISSN: | 0028-0836 1476-4687 |
DOI: | 10.1038/s41586-019-1735-9 |